chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tingling/numbness throughout my left hand and some in forearm / Sudden onset of pretty severe diffuse pain 1.5-2 days later in left shoulder, axilla, anterior chest wall; tingling/numbness throughout her left hand and some in forearm; tingling/numbness throughout her left hand and some in forearm; Sudden onset of pretty severe diffuse pain 1.5-2 days later in left shoulder, axilla, anterior chest wall; Sudden onset of pretty severe diffuse pain 1.5-2 days later in left shoulder, axilla, anterior chest wall; Sudden onset of pretty severe diffuse pain 1.5-2 days later in left shoulder, axilla, anterior chest wall; Sudden onset of pretty severe diffuse pain 1.5-2 days later in left shoulder, axilla, anterior chest wall; Intermittent discomfort in forearm; winging of her left scapula; weakness of serrates anterior; This is a spontaneous report from a contactable Other HCP (patient). A 42-years-old non-pregnant female patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EJ1685), via an unspecified route of administration in the right arm on 06Jan2021 07:45 at single dose for COVID-19 immunisation. Medical history included hypothyroidism, raynaud's symptom, orthopedic surgeries. Concomitant medication included levothyroxine (unknown manufacturer). The patient previously took aspirin and gabapentin and experienced drug hypersensitivity. On 18Jan2021 13:00 the patient experienced tingling/numbness throughout her left hand and some in forearm, sudden onset of pretty severe diffuse pain 1.5-2 days later (Jan2021) in left shoulder, axilla, anterior chest wall, persistent and consistent significant pain that does not change with position, ROM, or much with palpation, intermittent discomfort in forearm, evolving into the progressive weakness phase with significant winging of her left scapula and weakness of serrates anterior. Events resulted in emergency room visit and physician office visit. The events were evaluated by an MD who has given the patient a tentative diagnosis of Neuralgic Amyotrophy. Seeing a neurologist on 02Jan2021. The outcome of the events was not recovered. The patient received mediation to manage pain. The patient did not have COVID-19 prior to vaccination and was not covid tested post vaccination.
i had chills fever body aches headache earache very very sick on Friday. in bed all day friday saturday and sunday.  Friday was the worst. was almost back to  normal on Monday.
Rash on right side at waist and upper thigh; This spontaneous case was reported by a consumer and describes the occurrence of   in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Drug ineffective; Had covid after getting vaccinated; This is a spontaneous report received from a contactable reporter(s) (Physician) for a sponsored program.  A 63 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Rheumatoid arthritis" (ongoing). Concomitant medication(s) included: ENBREL taken for rheumatoid arthritis. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "Drug ineffective"; COVID-19 (medically significant), outcome "unknown", described as "Had covid after getting vaccinated". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive, notes: the patient had COVID (Coronavirus disease of 2019).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported drug ineffective and COVID-19 cannot be ruled out.
Itching with pink circle  around injection site first occurred on 3/7/2021 (date of vaccine 2/27/2021).  On 3/11/2021 circle was irregular and doubled in size.  It is warm to the touch and itches.  Physicians office has been contacted.  Haven't heard back yet.
For about three weeks, I had fatigue, subjective fever, myalgia, headaches, light headedness, and stomach upset.
headache; Fever; It's the extremities, from her wrist to the tips of her fingers and around her ankles to her toes; joint pain in fingers, hands, wrists, feet and toes/It's not like her entire body hurts, it's her shoulders, hips and elbows; It's the extremities, from her wrist to the tips of her fingers and around her ankles to her toesIt's the extremities, from her wrist to the tips of her fingers and around her ankles to her toes; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EW0162) via an unspecified route of administration, administered in Arm Left on 16Apr2021 14:00 (at the age of 42-year-old) as single dose for COVID-19 immunization. Medical history included ongoing hypothyroidism diagnosed in 2016. Concomitant medication(s) included levothyroxine taken for hypothyroidism from 2016 and ongoing. The patient did not have any history of previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines administered on same date of the Pfizer Suspect. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. The patient took the 1st dose on 16Apr2021, and it will be 2 weeks. The first evening (16Apr2021) was the worst headache she had ever felt in her life. She had a bad headache the next day, it lingered then it was fine. Then on the 17,18,19 headache got better. She prepared herself. She was running a fever and was not used to that. She had pain in her joints of her fingers, hands, wrist, feet and toes. It was not so painful that she could not function. The joint pain began a week after the shot, because her headache was so intense, she thinks it began the week of the 19th at midweek. If she takes Tylenol, it helps. It was definitely there. Patient worked as a medical writer and spend a lot of time on a computer, so it was definitely bothersome to her. She described it as trying to grip something, like holding a jar to open it. It was hurtful. Squeezing a lemon, these were mundane things, and nothing new to her. She wanted to build her immunity, and it was better to get the vaccine than get the infection and not be able to fight it. Patient enquired if other people experienced this kind of symptom. She knew headache, fever, body ache and fatigue. It's not like her entire body hurts, it's her shoulders, hips and elbows. It's the extremities, from her wrist to the tips of her fingers and around her ankles to her toes. AE(s) did not require a visit to Emergency Room or Physician Office. Her 2nd shot was scheduled for 07May2021. The patient had no relevant tests. Outcome of the event headache was recovered on 20Apr2021; fever was unknown; other events was not recovered.  No follow-up attempts are needed. No further information is expected
Client fainted after her vaccines were given. She was lowered to the floor and and became conscious after 30 seconds. She then was then monitored for 40 mins. Client was offered water and crackers. Her mother was notified and came to drive the client home.
Client had Moderna vaccines for Covid in April and May 2021.  Tested on 11/18 because son with who she lives was positive for Covid the week before.  Client tested positive and has no symptoms.
She was unresponsive for 10 to 15 seconds. Once she became responsive, she laid on the floor and we waited for EMS to arrive. She had no other reaction and refused further care after EMS checked on her.
Patient had gotten the Pfizer shot at our pharmacy on 8/23/21 and when he was getting the second dose at another facility they noticed that prior to getting Pfizer 1st dose he had gotten Jassen vaccine on 4/5/21 somewhere else. On the consent form patient had selected "No" for "Have you ever received a dose of COVID-19 vaccine." There are no known adverse events.
He started shaking.; He was walking crunched down by his back./He would walk really slow.; He had headaches.; He had chills.; He had fever around 104.; At midnight on same day, he was feeling hot.; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (At midnight on same day, he was feeling hot.), TREMOR (He started shaking.), GAIT DISTURBANCE (He was walking crunched down by his back./He would walk really slow.), HEADACHE (He had headaches.) and CHILLS (He had chills.) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Sep-2021, the patient experienced FEELING HOT (At midnight on same day, he was feeling hot.). On an unknown date, the patient experienced TREMOR (He started shaking.), GAIT DISTURBANCE (He was walking crunched down by his back./He would walk really slow.), HEADACHE (He had headaches.), CHILLS (He had chills.) and PYREXIA (He had fever around 104.). The patient was treated with IBUPROFEN at a dose of 1 dosage form. At the time of the report, FEELING HOT (At midnight on same day, he was feeling hot.), TREMOR (He started shaking.), GAIT DISTURBANCE (He was walking crunched down by his back./He would walk really slow.), HEADACHE (He had headaches.), CHILLS (He had chills.) and PYREXIA (He had fever around 104.) outcome was unknown.            Patient wants to know if there is any excuse note that can be provided to his work from moderna for not showing up to work and also wants to know if he should go to doctor if he has fever again.  No concomitant medication was reported.
Low grade fever within 6 days of vaccine followed by rash of small bumps throughout the body, lethargy, malaise.
This spontaneous report was received from a consumer (a daughter reported about her mother who is the 54-year-old patient as well as the physician). The patient's pertinent medical history included breast cancer few years ago. The patient's concomitant medications included medicines for breast cancer. On 13-APR-2019 (also reported as Saturday), the physician attempted to administer GARDASIL 9 injection to another unspecified patient and the content of the vaccine leaked onto the physician' s finger. The physician's finger "swelled and some of the vaccine content got under her skin which resulted in her skin to turn purple which occurred within only a few seconds." The swelling of the physician' s finger has lessened but the skin is still purple. The physician treated herself (accidental exposure to product, skin discolouration, peripheral swelling and exposure via skin contact). The outcome of skin discolouration and peripheral swelling was recovering. Causality of the events was not reported.
This spontaneous report was received from a physician, via a company representative, concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 08-APR-2016, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 with lot # L007720 Expiration date: 08-JUL-2018, 0.5 ml (route and anatomical location of administration were not reported). On unspecified dates, the PNEUMOVAX 23 had six temperature excursions of 0 Celsius Degrees (32 Fahrenheit) for 328 hours, 0.55 Celsius Degrees (33 Fahrenheit) for 128 hours, -1.11 Celsius Degrees (30 Fahrenheit) for 288 hours, -1.66 Celsius Degrees (29 Fahrenheit) for 256 hours, -0.55 Celsius Degrees (31 Fahrenheit) for 552 hours, and 1.11 Celsius Degrees (34 Fahrenheit) for 72 hours, respectively. The vaccine status was reported as "in excursion" and the type of excursion and storage criteria were reported as "refrigerator(R)". No adverse effects were reported nor Product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Information has been received from a medical assistant concerning an unknown number of patients of unknown age and gender. There was no information about the patients' medical history, concurrent conditions or concomitant therapies reported. On 21-FEB-2017, the patients were vaccinated with an improperly stored VAQTA intramuscularly, lot number reported as M027809 with expiration date of 24-JAN-2018;  lot number: M036459 with expiration date of 18-JAN-2018; lot number: M047658 with expiration date of 28-OCT-2017 (strength, dosage schedule and anatomical location were not provided) for prophylaxis, and the administered doses were exposed to a temperature higher than 8°C but lower than 25°C for 5 hours and 43 minutes (digital data logger) without any previous temperature excursion. No adverse effects were reported. There was no product quality complaint involved. Lot number [M027809] is an invalid lot number for VAQTA. This is one of two reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1702USA011533:
two days after vax: Arm was sore and a little aching, woke up with severe pain in left shoulder and neck. Pain slowly spread across shoulder down left arm. Could not move my head, unable to get up. Immediately called physician and was prescribed tylenol and warm compressants. No relief, after a few days on tylenol, started to feel a little relief. About a week later, symptoms disappeared.
This spontaneous report as received from an Emergency Medical Technician (EMT) refers to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant therapies were not reported. On an unknown date, the patients received improperly stored doses of PNEUMOVAX 23 (dose, route of administration, lot number and expiration date were not reported). It was stated that the vaccine underwent a temperature excursion of 63 degrees Fahrenheit for 564 hours. No previous excursion was reported. No data logger was involved. No adverse effects were reported. No product quality complaint (PQC) was involved. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Broke out in hives some hours after receiving first dose; did not make connection to vaccine until next day. Suffered 15 - 20 hives, very itchy for days into weeks; would subside and then be itchy again. Very slow to go away.   It is now 9 days after receiving vaccine. I am still breaking out in new hives, not as many as before, but very itchy and uncomfortable. I don't see hives listed as a side effect, but there is nothing else that has changed in my environment or diet. This seems excessive and far too long to be suffering side effects.
received first dose of vaccine and then tested positive for SARs-Cov-2; received first dose of vaccine and then tested positive for SARs-Cov-2; This is a spontaneous report from a contactable healthcare professional (patient). A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of vaccine and then tested positive for SARs-Cov-2 on an unspecified date. The patient was asking about the efficacy. Outcome of the events was unknown.  Information on the Lot/Batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 cannot be completely excluded for reported events.
Hives to arms & torso area an hour after vaccination, headache, dizziness, c/o of not feeling well & feeling like he would pass out even after BENADRYL IM, 25 mg given.
Approximately 21 hours after receiving woke up and was unable to move left arm, shoulder, neck.
Narrative: 75yr patient direct transfer from facility concerning for hypovolemic shock. Tested positive for COVID one week later while inpatient with COVID symptoms (HA, malaise, chills, body aches, and fever 99.9). Received Moderna Vaccine 2/24/2021 and 6/1/2021. PMH: CAD, uncontrolled T2DM (A1c 13%), COPD GOLD stage III, CKD3, GERD, RA (on immunosuppressant therapy -daily prednisone 5mg and etanercept), and gout with BMI >25 (@32). Did not require dexamethasone or COVID therapeutics while hospitalized and only on RA with SpO2 92. Had a prolonged hospitalization course for non-COVID related condition (~4-5 weeks).
feel feverish but no fever; really tired; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (feel feverish but no fever) and FATIGUE (really tired) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (feel feverish but no fever) and FATIGUE (really tired). At the time of the report, PYREXIA (feel feverish but no fever) and FATIGUE (really tired) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported. . Treatment unknown (either acetaminophen or ibuprofen)   This case was linked to MOD-2021-138792 (Patient Link).
Low-grade fever/Fever 101; Nausea; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (Low-grade fever/Fever 101) and NAUSEA (Nausea) in a 75-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Low-grade fever/Fever 101) and NAUSEA (Nausea). At the time of the report, PYREXIA (Low-grade fever/Fever 101) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: Low-grade and 101.         No concomitant medications were reported. It was reported that the patient ethnicity was provided. The patient had a reaction to Moderna shots. The patient woke up with nausea with the first one and had a low-grade fever. The patient had fever 101 with second shot. The doctor who was overseeing that and said for patient to not take another one because it could have been one of the derivatives in it and they had not known which one. No treatment medications were reported.   This case was linked to MOD-2022-636749 (Patient Link).
nasuea/vomitting migraine limb numbness weakness visual disturbances dizziness hands  blotchy and clamy
I've been experiencing a shortness of breath and difficulty taking a deep breath at times for about a week.
Fluid, spots on lungs, muscle hardening, capillary leakage, ankle pain, joint stiffness.
pt recvd vax & devel burning sensation in the shoulder, radiating up to the neck; later devel neck stiffness self treated w/advil;
fever of greater than 102; headache; fatigue; chest heaviness; This spontaneous case was reported by a health care professional and describes the occurrence of PYREXIA (fever of greater than 102), HEADACHE (headache), FATIGUE (fatigue) and CHEST DISCOMFORT (chest heaviness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever of greater than 102), HEADACHE (headache), FATIGUE (fatigue) and CHEST DISCOMFORT (chest heaviness). At the time of the report, PYREXIA (fever of greater than 102), HEADACHE (headache) and CHEST DISCOMFORT (chest heaviness) outcome was unknown and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Moderna 2/16/21, 3/16/21. Positive on 1/28/22
It began with feet and toes going numb / painful / stiff/pins and needles / paralysis / neuropathy; these same symptoms also spread to the hands and was rapidly followed by severe balance and coordination issues. I was admitted to Hospital and eventually diagnosed with Guillain-Barre syndrome. Hospital course was IVIG, lumbar puncture, MRIs, respiratory tests, urological tests, many neurological test, EKGs, nerve induction test, urinalysis, many blood draws, physical therapy, occupational therapy, speech services and other tests and treatments I don't recall. I was eventually discharged to hospitalized rehabilitation, followed by physical therapy occupational therapy and speech therapy at home and then eventually outpatient physical therapy occupational therapy and speech services which I am still attending. Multiple issues have manifested/not resolved.
Nursing student cleaned guests arm, inserted needle/syringe. The syringe was fighting her, she tried retracting and it would not retract completely so she went to withdraw. When she went to withdraw the vaccine came out of the guest's arm. Ultimately the decision was made to give a second dose.
Rash on face, swollen face including around the eye area, torso was covered with a rash, rash spread to scalp, arms and legs, rash became worse covering his entire body
Information has been received from a physician concerning a female patient who on unspecified date was vaccinated with a dose of GARDASIL (Lot# not reported). The physician stated that the patient received GARDASIL and got human papilloma viral infection (HPV) anyway. At the time of the report the patient's outcome was unknown. It was unspecified if the patient sought medical attention. Additional information has been requested.
This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about concomitant medication, pertinent medical history and drug reactions/allergies was not provided. On 05-DEC-2018, the patient was vaccinated with improperly stored RECOMBIVAX HB (lot # R001084, expiration date 07-NOV-2020) for prophylaxis (strength, dose detail, anatomical location and route of administration were not reported). On 02-JAN-2019, the patient was vaccinated with improperly stored ROTATEQ (lot # R015435, expiration date 17-APR-2020) for prophylaxis (strength, dose detail, anatomical location and route of administration were not reported). No adverse effect was reported. The vaccines were exposed to temperature excursion between 0 degree Celsius (C) and 1 degree C for a time frame of 19 minutes and between 9 degree C and 25 degree C for 1 hour without previous temperature excursion. Data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1901USA001125.
24 hours after IM injection of #5 dose DTaP administered a faint pink rash on arm at site and upper back, no difficulty breathing.
I had  diarrhea after 23 hours after I got the Covid-19  Vaccine/Moderna. The diarrhea last for 10 hours.  I took eight pepto-bismol capsules in the 10 hours.